Quarterly Results

  • Company Name :
Concord Biotech Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 543960
  • NSE Symbol:
  • CONCORDBIO
  • P/E(TTM):
  • 49.42
  • ISIN Demat:
  • INE338H01029
  • Div & Yield%:
  • 0.61
  • EPS(TTM):
  • 35.65
  • Book Value(₹):
  • 173.27
  • Market Cap(₹Cr.):
  • 18,431.81
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 429.88 244.22 310.18
Excise Duty 0.00 0.00 0.00
Net Sales 429.88 244.22 310.18
Other Operating Income 0.00 0.00 0.00
Other Income 9.38 14.73 10.03
Total Income 439.27 258.95 320.21
Total Expenditure 239.46 146.27 173.50
PBIDT 199.81 112.68 146.70
Interest 0.10 0.10 0.10
PBDT 199.71 112.58 146.61
Depreciation 14.62 13.26 13.31
Tax 41.82 23.69 34.06
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 1.34 1.54 0.53
Reported Profit After Tax 141.94 74.09 98.70
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 141.94 74.09 98.70
EPS (Unit Curr.) 13.57 7.08 9.43
EPS (Adj) (Unit Curr.) 13.57 7.08 9.43
Calculated EPS (Unit Curr.) 13.57 7.08 9.43
Calculated EPS (Adj) (Unit Curr.) 13.57 7.08 9.43
Calculated EPS (Ann.) (Unit Curr.) 54.27 28.33 37.74
Calculated EPS (Adj) (Ann.) (Unit Curr.) 54.27 28.33 37.74
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 10.46 10.46 10.46
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 46.48 46.14 47.30
PBDTM(%) 46.46 46.10 47.27
PATM(%) 33.02 30.34 31.82